Your liver's alcohol-processing capacity remains unchanged, but the timing and intensity of absorption shift significantly
Key Trial Results CagriSema delivered solid weight loss, but not enough to meet the primary endpoint of non-inferiority versus tirzepatide
This lipidization significantly extends its half-life, allowing for prolonged observation in research settings
However, there is potential for more serious adverse effects, such as: 1 Vision problems Swelling in the extremities Dizziness or fainting Reduced urination Rash Rapid heart rate Swelling of the throat, tongue, mouth, face, or eyes Problems swallowing or breathing Fever Yellow eyes or skin Chronic upper stomach pain Wegovy, another brand name for semaglutide, may also cause damage to the retina, suicidal ideation, gallstones, pancreatitis, and acute kidney damage
Retatrutide vs Semaglutide and Tirzepatide Retatrutide, semaglutide, and tirzepatide are all long-acting GLP-1 receptor agonists or related receptor agonists used in obesity and type 2 diabetes management